White-matter-nulled MPRAGE at 7T reveals thalamic lesions and atrophy of specific thalamic nuclei in multiple sclerosis

Investigating the degeneration of specific thalamic nuclei in multiple sclerosis (MS) remains challenging. White-matter-nulled (WMn) MPRAGE, MP-FLAIR, and standard T1-weighted magnetic resonance imaging (MRI) were performed on MS patients ( n = 15) and matched controls ( n = 12). Thalamic lesions we...

Full description

Saved in:
Bibliographic Details
Published inMultiple sclerosis p. 1352458519828297
Main Authors Planche, Vincent, Su, Jason H, Mournet, Sandy, Saranathan, Manojkumar, Dousset, Vincent, Han, May, Rutt, Brian K, Tourdias, Thomas
Format Journal Article
LanguageEnglish
Published England 01.07.2020
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:Investigating the degeneration of specific thalamic nuclei in multiple sclerosis (MS) remains challenging. White-matter-nulled (WMn) MPRAGE, MP-FLAIR, and standard T1-weighted magnetic resonance imaging (MRI) were performed on MS patients ( n = 15) and matched controls ( n = 12). Thalamic lesions were counted in individual sequences and lesion contrast-to-noise ratio (CNR) was measured. Volumes of 12 thalamic nuclei were measured using an automatic segmentation pipeline specifically developed for WMn-MPRAGE. WMn-MPRAGE showed more thalamic MS lesions ( n = 35 in 9 out of 15 patients) than MP-FLAIR ( n = 25) and standard T1 ( n = 23), which was associated with significant improvement of CNR ( p < 0.0001). MS patients had whole thalamus atrophy ( p = 0.003) with lower volumes found for the anteroventral ( p < 0.001), the pulvinar ( p < 0.0001), and the habenular ( p = 0.004) nuclei. WMn-MPRAGE and automatic thalamic segmentation can highlight thalamic MS lesions and measure patterns of focal thalamic atrophy.
ISSN:1477-0970
DOI:10.1177/1352458519828297